Corrigendum: Sorafenib increases cytochrome P450 lipid metabolites in patient with hepatocellular carcinoma
oleh: Can G. Leineweber, Can G. Leineweber, Can G. Leineweber, Miriam Rabehl, Miriam Rabehl, Anne Pietzner, Anne Pietzner, Nadine Rohwer, Nadine Rohwer, Nadine Rohwer, Michael Rothe, Maciej Pech, Bruno Sangro, Rohini Sharma, Chris Verslype, Bristi Basu, Christian Sengel, Jens Ricke, Nils Helge Schebb, Karsten-H. Weylandt, Karsten-H. Weylandt, Julia Benckert
| Format: | Article |
|---|---|
| Diterbitkan: | Frontiers Media S.A. 2024-01-01 |
Deskripsi
Subjek
hepatocellular carcinoma; cytochrome P450; sorafenib; EET; EDP; omega-3 fatty acids